Cao-Lormeau VM, 2011 PDF

Recent Emergence of Dengue Virus Serotype 4 in French
Polynesia Results from Multiple Introductions from Other

South Pacific Islands
Van-Mai Cao-Lormeau
1
*, Claudine Roche
1
, Maite Aubry
1
, Anita Teissier
2
, Ste phane Lastere
2
, Elise
Daudens
3
, Henri-Pierre Mallet
3
, Didier Musso
2
, John Aaskov
4
1Laboratoire de recherche en virologie medicale, Institut Louis Malarde, Papeete, Tahiti, French Polynesia, 2Laboratoire danalyses de biologie medicale, Institut Louis
Malarde , Papeete, Tahiti, French Polynesia, 3Bureau de veille sanitaire, Direction de la sante, Papeete, Tahiti, French Polynesia, 4Queensland University of Technology,
Brisbane, Australia
Abstract
Background: Infection by dengue virus (DENV) is a major public health concern in hundreds of tropical and subtropical
countries. French Polynesia (FP) regularly experiences epidemics that initiate, or are consecutive to, DENV circulation in
other South Pacific Island Countries (SPICs). In January 2009, after a decade of serotype 1 (DENV-1) circulation, the first cases
of DENV-4 infection were reported in FP. Two months later a new epidemic emerged, occurring about 20 years after the
previous circulation of DENV-4 in FP. In this study, we investigated the epidemiological and molecular characteristics of the
introduction, spread and genetic microevolution of DENV-4 in FP.
Methodology/Principal Findings: Epidemiological data suggested that recent transmission of DENV-4 in FP started in the
Leeward Islands and this serotype quickly displaced DENV-1 throughout FP. Phylogenetic analyses of the nucleotide
sequences of the envelope (E) gene of 64 DENV-4 strains collected in FP in the 1980s and in 20092010, and some additional
strains from other SPICs showed that DENV-4 strains from the SPICs were distributed into genotypes IIa and IIb. Recent FP
strains were distributed into two clusters, each comprising viruses from other but distinct SPICs, suggesting that emergence
of DENV-4 in FP in 2009 resulted from multiple introductions. Otherwise, we observed that almost all strains collected in the
SPICs in the 1980s exhibit an amino acid (aa) substitution V287I within domain I of the E protein, and all recent South Pacific
strains exhibit a T365I substitution within domain III.
Conclusions/Significance: This study confirmed the cyclic re-emergence and displacement of DENV serotypes in FP.
Otherwise, our results showed that specific aa substitutions on the E protein were present on all DENV-4 strains circulating
in SPICs. These substitutions probably acquired and subsequently conserved could reflect a founder effect to be associated
with epidemiological, geographical, eco-biological and social specificities in SPICs.
Citation: Cao-Lormeau V-M, Roche C, Aubry M, Teissier A, Lastere S, et al. (2011) Recent Emergence of Dengue Virus Serotype 4 in French Polynesia Results from
Multiple Introductions from Other South Pacific Islands. PLoS ONE 6(12): e29555. doi:10.1371/journal.pone.0029555
Editor: Eng Eong Ooi, Duke-National University of Singapore Graduate Medical School, Singapore
Received June 30, 2011; Accepted November 30, 2011; Published December 28, 2011
Copyright: 2011 Cao-Lormeau et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Fonds de Cooperation Economique, Sociale et Culturelle pour le Pacifique -Ministe`re des Affaires Etrange` res et
Europe ennes, France (Conventions Nu138/1/2008, 75/1/2009), (URL: http://www.diplomatie.gouv.fr) and by the Agence nationale pour la Recherche, France
(De cision attributive daide NuANR-09-MIEN-028-01), URL: http://www.agence-nationale-recherche.fr. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: mlormeau@ilm.pf
Introduction
Almost all tropical and subtropical regions of the world are
concerned by the risk of dengue. Every year, dengue virus (DENV)
causes more than 50 million infections, 500 000 hospitalizations
and 12 500 deaths, mostly children [1]. Currently there is no
vaccine or effective anti-viral therapy and vector control measures
regularly fail to prevent the emergence of dengue epidemics.
DENV is a single-stranded, positive-sense RNA virus belonging to
the genus Flavivirus, family Flaviviridae, transmitted by Aedes
mosquitoes, principally Aedes (Stegomyia) aegypti but also Aedes
albopictus and some endemic vectors, like Aedes polynesiensis in the
Polynesian triangle [2]. Infection with dengue virus may result in a
wide spectrum of clinical manifestations accounting for the
classification of the disease as dengue (fever, rash, headache,
myalgia, arthralgia, nausea, vomiting) with or without warning
signs (abdominal pain, persistent vomiting, clinical fluid accumu-
lation, mucosal bleed) or severe dengue (characterized by plasma
leakage) with or without hemorrhage [3]. There are four distinct
serotypes of dengue virus (DENV-1 to -4) and infection with one
serotype provides no long-term cross-protective immunity against
the three others. Based on the sequence of the envelope gene (E),
each serotype may be divided into distinct phylogenetic clusters or
genotypes [4]. Both epidemiological observations and in vitro
studies suggest that some genotypes may have different epidemic
potential [57].
In the South Pacific, the earliest dengue epidemics may have
occurred during the nineteenth century [8]. However, dengue only
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e29555
Table 1. Characteristics of the 64 DENV-4 strains used for E-gene sequence analysis.
ID Country Archipelago Island District Year GenBank
NC09/060209-1528 NC 2009 JN832498
WF09/010409-0001 WF 2009 JN832499
PF-NC09/160109-136 PF (imp. from NC) Tahiti Mahina 2009 JN832507
PF82/5918 PF Windward Islands Tahiti 1982 JN832500
PF83/6074 Tahiti 1983 JN832501
PF84/131-188 Tahiti 1984 JN832502
PF85/323-103 Tahiti 1985 JN832503
PF86/50-70 Tahiti 1986 JN832504
PF87/19-7 Tahiti 1987 JN832505
PF09/060309-96 Tahiti Papeari 2009 JN832514
PF09/130309-109 Tahiti Punaauia 2009 JN832519
PF09/160309-24 Tahiti Mahina 2009 JN832520
PF09/310309-162 Tahiti Pirae 2009 JN832524
PF09/270409-182 Tahiti Faaa 2009 JN832530
PF09/150609-91* Tahiti Punaauia 2009 JN832536
PF09/220709-54* Tahiti Punaauia 2009 JN832541
PF09/220909-50 Tahiti Papeete 2009 JN832545
PF09/041109-131 Tahiti Papara 2009 JN832547
PF09/041209-32 Tahiti Arue 2009 JN832548
PF10/010410-215 Tahiti Mahina 2010 JN832555
PF10/170510-92 Tahiti 2010 JN832558
PF10/150610-28 Tahiti Papara 2010 JN832561
PF09/020309-54 Moorea 2009 JN832512
PF09/190809-58 Moorea 2009 JN832543
PF10/190110-98 Moorea 2010 JN832550
PF10/010310-32 Moorea 2010 JN832553
PF09/090309-122 Leeward Islands Raiatea 2009 JN832516
PF09/080409-93 Raiatea 2009 JN832526
PF09/040509-242 Raiatea 2009 JN832531
PF09/120609-125 Raiatea 2009 JN832535
PF09/270709-74 Raiatea 2009 JN832542
PF09/230209-116 Bora Bora 2009 JN832509
PF09/100309-172 Bora Bora 2009 JN832517
PF09/100309-208 Bora Bora 2009 JN832518
PF09/190509-238 Bora Bora 2009 JN832533
PF09/200809-131 Bora Bora 2009 JN832544
PF09/290109-69 Tahaa 2009 JN832508
PF09/270209-213 Tahaa 2009 JN832511
PF09/030309-39 Tahaa 2009 JN832513
PF09/060309-198 Tahaa 2009 JN832515
PF09/210409-134 Maupiti 2009 JN832527
Recent Emergence of DENV-4 in French Polynesia
became a significant health problem during World War II, because
of the spread of the main dengue vector, Ae. aegypti. The first
documented outbreak of DENV in the South Pacific occurred in
19431944 and was due to serotype 1. When dengue reappeared 20
years later in French Polynesia (FP) it was due to DENV-3 [910].
The first cases of severe dengue in the Pacific were reported in the
1970s [1113]. Beginning in 2000, outbreaks of DENV in South
Pacific Island Countries (SPICs) have been due to DENV-1 [1419]
but in 2008, DENV-4 circulation was detected [2022] for the first
time since the 1980s [23,24]. In January 2009, about 20 years after
the last reported case, DENV-4 was detected in two members from
the same family returning to FP from New Caledonia (NC) where
this serotype had recently been detected. Two months later FP
experienced a large dengue outbreak.
Here, we report the epidemiological and molecular character-
istics of the introduction, spread and genetic microevolution of
DENV-4 in FP.
Materials and Methods
Epidemiological and biological data
Laboratory diagnosis of dengue was performed on sera from
dengue suspected patients using ELISA tests for the detection of
either DENV NS1 (Platelia
TM
Dengue NS1 Ag, Bio-Rad
Laboratories, Marnes-la-Coquette, France) or anti-DENV IgM
(Dengue IgM Capture ELISA, Panbio Diagnostics, Brisbane,
Australia). A DENV serotype-specific multiplex real-time RT-
PCR using primers and probes designed by Johnson et al. (2005)
[25] was performed on sera containing DENV NS1 or from
patients who have travelled recently to areas where dengue is
known to occur. Data from January 2009 to December 2010 were
recorded by the Health Department (Bureau de Veille Sanitaire,
Tahiti, French Polynesia) based on reports transmitted by Institut
Louis Malarde (ILM, Tahiti, French Polynesia) and the principal
hospital in Tahiti (Centre Hospitalier de la Polynesie Francaise).
Viruses
The details of the viruses employed are shown in Table 1.
Briefly, DENV-4 strains collected in FP in the 1980s were
obtained from the DENV collection of ILM. At the time they were
collected, these strains were amplified by one passage on C6/36
Ae. albopictus cells and cell supernatants were then preserved at
280uC. DENV-4 strains recently collected in FP were obtained
from sera positive by DENV-4 real-time RT-PCR performed by
the clinical laboratory from ILM. One of these sera was recovered
from a patient recently returned from NC [PF-NC09/160109-
136]. Two additional DENV-4 strains collected in NC and Wallis
& Futuna [NC09/060209-1528, WF09/010409-0001] were
kindly provided by Dr M Dupont-Rouzeyrol, Institut Pasteur de
Nouvelle Caledonie, and Dr JF Yvon, clinical laboratory from Sia
Hospital, Wallis. Five additional strains collected in the SPICs in
20082009 [Kiribati KI08/266, Tonga TO08/14, Fiji FJ08/
3953, Vanuatu VU09/4214 and Western Samoa WS08/73] were
sequenced as previously described [22]. Additional E gene
sequences of 73 strains were retrieved from GenBank.
Ethics statement
All dengue virus strains were obtained from sera initially
sampled for dengue diagnostic and surveillance purposes (under
medical prescription by a physician), and archived at ILM. The
only information provided to the research laboratory was the
sample laboratory ID number, the date of collection and the
district/island of collection (no personal information on the patient
was provided). The use of biological samples and the collection of
information were performed in accordance with the French
regulations.
Nucleotide sequencing
Sera or whole blood on filter paper cards (LDA
22
, France) were
used as a source of DENV. RNA was extracted from sera using the
QIAampH Viral RNA Mini Kit (Qiagen, Germany) or the
Easymag extraction system (Biomerieux, France) according to
manufacturers instructions. For whole blood, five filter paper
spots per patient were incubated for 20 min at room temperature
in lysis buffer from the QIAampH Viral RNA Mini Kit. After
centrifugation for 10 min at 8000 rpm, the extraction process was
pursued using the supernatant, according to the manufacturers
instructions. Amplification of the E gene was then performed using
ID Country Archipelago Island District Year GenBank
PF09/190509-37 Maupiti 2009 JN832532
PF09/160609-119 Maupiti 2009 JN832537
PF88/130-74 Marquesas archipelago 1988 JN832506
PF09/240209-38 Ua Pou 2009 JN832510
PF09/270309-27 Ua Pou 2009 JN832522
PF09/270309-31 Ua Pou 2009 JN832523
PF09/081209-283 UaPou 2009 JN832549
PF09/290509-25 Nuku Hiva 2009 JN832534
PF09/070409-227 Australes archipelago Rimatara 2009 JN832525
PF09/230409-06 Rurutu 2009 JN832528
PF09/250609-14 Rurutu 2009 JN832538
PF09/240409-72 Tuamotu archipelago Hao 2009 JN832529
PF09/210709-11 Hao 2009 JN832540
PF09/080709-23 Manihi 2009 JN832539
*patient with severe dengue.
doi:10.1371/journal.pone.0029555.t001
Table 1. Cont.
Table 2. Spatial and temporal distribution of confirmed cases of DENV-1 and DENV-4 infections between January and December
2009.
Society archipelago
Marquesas
archipelago
Austral
archipelago
Tuamotu
archipelago
Gambier
archipelago
Total Windward Islands Leeward Islands
January
DENV-1 11 Tahiti 11
DENV-4 3 Tahiti 2 Tahaa 1
February
DENV-1 29 Tahiti 29
DENV-4 10 Tahiti 1 Tahaa 3 Ua Pou 1
Bora Bora 5
March
DENV-1 39 Tahiti 37
Moorea 2
DENV-4 132 Tahiti 41 Tahaa 42 Ua Pou 3
Moorea 3 Bora Bora 33
Raiatea 10
April
DENV-1 20 Tahiti 17 Raiatea 1
Moorea 2
DENV-4 262 Tahiti 130 Tahaa 14 Ua Pou 8 Rimatara 1 Hao 2
Moorea 25 Bora Bora 55 Nuku-Hiva 1 Rurutu 2
Raiatea 21 Fatu-Hiva 1
Maupiti 2
May
DENV-1 2 Tahiti 2
DENV-4 126 Tahiti 80 Bora Bora 9 Ua Pou 4 Tubuai 1
Moorea 10 Raiatea 9 Nuku-Hiva 6
Maupiti 4 Ua Huka 1
Huahine 2
June
DENV-1 1 Tahiti 1
DENV-4 165 Tahiti 112 Bora Bora 4 Nuku-Hiva 1 Rurutu 6 Hao 4
Moorea 13 Raiatea 15 Raivavae 2 Fakarava 3
Maupiti 2 Manihi 1
Huahine 1 Rangiroa 1
July
DENV-4 35 Tahiti 23 Raiatea 1 Fatu-Hiva 1 Hao 1
Moorea 4 Huahine 1 Manihi 4
August
DENV-4 7 Tahiti 3 Bora Bora 1 Hao 1
Moorea 2
September
DENV-4 9 Tahiti 5 Nuku-Hiva 2 Mangareva 1
Hiva-Oa 1
October
DENV-4 5 Tahiti 4 Rangiroa 1
November
DENV-4 2 Tahiti 2
December
DENV-4 7 Tahiti 6 Ua Pou 1
the OneStep RT-PCRH Kit (Qiagen, Germany) and two manually
designed oligonucleotides primer pairs [D4E/777F (59- GCT TGG
AAA CAT GCT CAG AG-39) and D4E/1766R (59- ACA TGT GGT
TTC CAT CAC CG-39); D4E/1639F (59-TGG TGA CAT TCA AGG
TTC CTC-39) and D4E/2509R (59-ACT GTT CTG TCC AAG TGT
GC-39)] in order to produce two overlapping fragments covering
the complete E gene. For two sequences [PF09/270309-27, PF09/
270309-31], a second round of PCR was required to obtain
sufficient DNA. The PCR products were purified using the
QIAquick PCR Purification Kit (Qiagen, Germany), the subse-
quent sequencing reactions performed with the ABI PRISMH
BigDye
TM
Terminator Cycle Sequencing Ready Reaction Kit
(Applied Biosystems, USA). and the product analyzed on the ABI
Prism 310 automated sequencer (Perkin-Elmer, Applied Biosys-
tems). Overlapping nucleotide sequences were assembled with
AutoAssembler software (Perkin Elmer). Nucleotide sequences
were aligned with the multiple sequence alignment software
ClustalW integrated in MEGA version 5 [26]. Phylogenetic
analysis was performed with MEGA5 using the Maximum
likelihood based on the Kimura 2-parameter method [27]. The
robustness of the original tree was tested with 1000 bootstrap
replications [28]. Sequences available on GenBank and corre-
sponding to strains belonging to all major branches of previously
published DENV-4 phylogenies were included in the analysis and
selected to maximize the representation of genotypes, countries
and years of isolation. Those that were very closely related to one
another in the data set were removed from the analysis. Mean
distances between and within groups were calculated for all
sequences (MEGA5).
Results
Epidemiology
Two patients with DENV-4 infections were detected in January
2009 in Tahiti, Society Islands. The patients were members from
the same family recently returned from NC where a DENV-4
outbreak had recently commenced concomitantly with DENV-1
transmission. These were the first cases of infection with DENV-4
detected in FP for more than 20 years. The French Polynesia
Public Health and Hygiene Department immediately applied
vector control measures by spraying insecticide against adult
mosquitoes and destroying breeding sites around the home of
these patients. The insecticide treatment was repeated 10 days
later. No new DENV-4 cases were detected in Tahiti in the
following weeks. However, at the end of February, DENV-4 was
detected in three patients living in Tahaa, five in Bora-Bora, one
in Tahiti (Society Islands) and one in Ua Pou (Marquesas Islands).
None of these patients had traveled out from FP during the two
previous weeks. An additional patient from Tahaa with an onset
of symptoms at the end of January was found subsequently, by
RT-PCR, to also have had a DENV-4 infection. From January to
March 2009, the number of patients with DENV-4 infections
increased dramatically and DENV-4 had displaced DENV-1 3
months later (Table 2). From January 2009 to December 2010,
Figure 1. Monthly recorded dengue suspected and confirmed cases from January 2009 to December 2010.
doi:10.1371/journal.pone.0029555.g001
ILM reported 8375 presumptive cases of dengue to the Health
Department, of which 2629 were confirmed subsequently by
serological or virological testing. One hundred of these were due to
DENV-1 and 763 to DENV-4 infections (Figure 1). During this
period, 87 hospitalizations were reported of which three were
dengue severe cases.
Molecular epidemiology of DENV-4 in FP
The 64 E gene sequences generated in the present study were
combined with 5 E gene sequences from DENV-4 strains collected
in the South Pacific between 2008 and 2009 and a data set of 73 E
gene sequences available on GenBank representing the global
genetic variability of DENV-4 (Figure 2). The phylogenetic tree
shows four distinct clusters named genotype I, II, III and IV.
These four clusters have been previously described as genotype I
or Southeast Asia, II or Indonesia, III, and IV or Sylvatic or
Malaysia [6,2931]. All sequences of DENV-4 collected in the
South Pacific belonged to genotype II. The average distances
between genotype II and the three others varied from 0.073 to
0.156, with standard errors (SE) of 0.005 and 0.011 respectively.
Within genotype II, viruses clustered into two distinct clades
previously defined as IIa and IIb [32]. The average distance
between these two clades is 0.063 with a SE of 0.007. The Clade
IIb consisted of strains isolated from 1979 to 2008 in the South
Pacific, the Caribbean, South and Central America, along with
two strains isolated in Indonesia in 1976 and 1977. Within clade
IIb, viruses collected in FP from 1983 to 1988 formed a distinct
group supported by a bootstrap value of 99% which we have
called the PF80s group. Clade IIa was composed, almost
exclusively, of viruses collected in the South Pacific and Southeast
Asia since 2000. Within clade IIa, all DENV-4 strains collected in
the South Pacific from 2007 to 2010 formed a distinct group
supported by a bootstrap value of 100% and which we have
named the Oceania group. Within the Oceania group, the strains
collected in FP were distributed into two clusters (Figure 3). The
first one, PF/NC/VU, comprised most (83%) of the FP strains and
was close to the strains from NC and Vanuatu. The second cluster,
PF/WF, included nine FP strains and was closer to the strain from
Wallis & Futuna. Within each cluster, several FP strains shared
identical E gene consensus sequences.
Based on the Solomon Island [SB07/EU448462] E gene
sequence, 53 sites exhibited a nucleotide (nt) substitution of which
18 were present on more than one strain but didnt lead to an
amino acid (aa) substitution (Table 3). The analysis of the 142 E
gene sequences included in this study revealed 79 aa mutated sites,
of which one aa substitution (T365I) was specifically encountered
within the Oceania group and another (V287I) was only found in
the PF80s group (Table 4).
Discussion
The recent emergence of DENV-4 in the SPICs occurred after
a decade of active DENV-1 circulation and about 20 years after
the previous circulation of DENV-4 in the region [23,24]. This
observation is consistent with previous epidemiological data
Figure 2. Evolutionary relationships of DENV-4 E gene
sequences. ML original tree derived from 110 DENV-4 E gene
sequences. The percentage of replicate trees in which the associated
taxa clustered together in the bootstrap test (1000 replicates) is shown
for values over 80. The number of strains with identical E gene
sequence is indicated in parenthesis (these additional strains could have
been collected in a different district or island and at a different date
than the strain that appears in the tree).
suggesting that, in the region and particularly in FP, sustained
transmission of a predominant serotype/genotype occurs following
a 20 to 25 years periodic cycle [33,34]. DENV-1 was still
circulating in FP when DENV-4 started to be transmitted locally,
but from July 2009, by performing DENV serotype-specific RT-
PCR on all sera previously tested positive using NS1 test, we only
found DENV-4 (Table 2). Up to November 2011, the only
DENV-1 case reported was a traveler just coming back from San-
Martin, Caribbean (data not shown). Previous studies already
demonstrated that the sensitivity of the Platelia
TM
Dengue NS1 Ag
test depends on the infecting DENV serotype, however the
sensitivity of the test was found to be at least identical or higher for
DENV-1 compared to DENV-4 [35,36]. Our results suggest that
DENV-4 displaced DENV-1. Consistently, the displacement of
the DENV serotype previously circulating by the newly introduced
serotype is a characteristic that has been constantly observed in FP
over time [33,34].Since the second semester of 2008, at the time
the transmission of DENV-4 in the South Pacific region was
dramatically increasing, dengue surveillance was reinforced in FP.
However, despite an active tracking, health authorities did not
reach to prevent and control the introduction of DENV-4 in FP.
Beside the two DENV-4 cases imported from NC to Tahiti in mid-
January, additional introduction events that remained undetected
might have occurred, particularly in the Leeward islands (Society
Islands) where the firsts cases due to local transmission were
reported (Table 2). Additional DENV-4 cases were then
Figure 3. Evolutionary relationships of DENV-4 Oceania group within clade IIa. ML original tree derived from 63 DENV-4 E gene sequences.
The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) is shown next to the
branches.
Table 3. Significant nucleotide substitutions on the E gene (1485 bp) within the DENV-4 clade IIa Oceania group.
nt positions
Cluster Strains 15 63 213 273 375 498 549 606 657 738 885 957 978 1146 1365 1386 1446 1465
none SB07/EU448462 G C A T A C C A T G G A T T T A T C
KI08/266 - - - - - - - - - - - - - - - - - -
WS08/73 - - - - - - - - - - - - - - - - - -
PF/WF WF09/010409-0001 - - - - T - - - - - - - - - - - - -
Punaauia 09 Group (3 strains) - - - - T - - - - - - - - - - - - T
PF09/310309-162 Tahiti-Pirae - - - - T - - - - - - - - - - - - T
PF09/270409-182 Tahiti-Faaa - - - - T - - - - - - - - - - - - T
PF09/190509-238 Bora Bora - - - - T - - - - - - - - - - - - T
Punaauia 10a Group (2 strains) - - - - T - - - C - - - - - C - - T
PF10/150610-28 Tahiti-Papara - - - - T - - - C - - - - - C - - T
none FJ08/3953 - - - - - - - - - - - - - - - G - -
TO08/14 - - - - - - - - - - - - - - - G - -
PF/NC/VU VU09/4214 - - - - - - - - - A - - - - - G - -
PF-NC09/160109-136 Tahiti-Mahina - - - - - - T - - A - - - - - G - -
NC09/060209-1528 - - - - - - T - - A - - - A - G - -
PF09/10 Group (25 strains) - - - - - - - - - A - - - A - G - -
PF09/100309-208 Bora Bora - - - - - - - - - A - - - A - G - -
PF09/120609-125 Raiatea - - - - - - - - - A - - - A - G - -
PF09/141009-111 Tahiti-Papeete - - - - - - - - - A - - - A - G - -
PF09/041209-32 Tahiti-Arue - - - - - - - - - A - - - A - G - -
PF09/081209-283 Marquesas-Ua Pou - - - - - - - - - A - - - A - G - -
PF10/050210-117 Tahiti-Punaauia - - - - - - - - - A - - - A - G - -
PF10/170510-192 Tahiti-Punaauia - - - - - - - - - A - - - A - G - -
Maupiti 09 Group (4 strains) A - - C - - - - - A - - - A - G - -
PF09/080409-93 Raiatea - - - - - - - - - A - G - A - G - -
PF09/270709-74 Raiatea - - - - - - - - - A - G - A - G - -
PF09/240409-72 Tuamotu-Hao - - - - - T - - - A - - - A - G - -
PF09/210709-11 Tuamotu-Hao - - - - - T - - - A - - - A - G - -
PF09/080709-23 Tuamotu-Manihi - T - - - - - - - A - - - A - G - -
Moorea 10 Group (2 strains) - T G - - - - - - A A - - A - G C -
Punaauia 10b Group (2 strains) - - - - - - - G - A - - C A - G - -
- Identical to Solomon.
progressively reported in other FP archipelagos, the spread of the
virus being supported by the high frequency of inter-island travel,
mostly by plane. Reminding that the DENV-1 epidemic in 2001
also started in the Leeward Islands [23], this place should be
considered as a main entry point for new emergent DENV
serotypes. Consistently, the Leeward Islands, notably Bora Bora,
are major touristic stations in FP.
In order to complement the epidemiological data and get a
better understanding of the events that might have led to the
introduction and spread of DENV-4 in FP, we conducted a
phylogenetic analysis on the complete E gene of DENV-4 strains
collected recently and in the 1980s in FP. We also included in the
study some strains collected in other SPICs in 20082009 and
additional sequences available on GenBank (Figure 2). The
resulting phylogenetic tree displays the four distinct genotypes
already described [4,2931]. Furthermore, it shows that DENV-4
strains collected in FP, both in the 1980s and in 20092010,
belong to genotype II and are distributed in clades IIa and IIb
[4,32]. These two clades are distant from more than 6% of genetic
divergence and could be therefore reasonably classified in two
distinct genotypes [4]. Clearly, these clades evolved separately
from a common ancestor originating from South-East Asia.
Interestingly, only clade IIa continued to circulate beyond the year
2000 in Southeast Asia and in the Pacific region. In contrast
strains belonging to clade IIb were isolated in Central and South
America and in the Caribbean at least until 2008 [37,38]. Indeed,
DENV-4 genotype IIb is still predominating in the Americas. The
replacement of genotype IIb by the genotypes predominating in
Southeast Asia (I, IIa, III, IV) did not occur; although
introductions of genotype I were reported in Brazil in 2007 [39].
This contrasts with the situation observed for DENV-2, where the
Southeast Asian genotype totally replaced the American genotype
previously circulating [40,41].
Our results corroborate previous studies showing that both in
the 1980s and in the early year 2000, DENV-4 had been
introduced into the region from Southeast Asia [22,24,30]. In
addition, we found that all FP strains along with other DENV-4
strains recently collected in the SPICs form a distinct group rooted
by the Solomon Island strain [SB07/EU448462], we called
Oceania group (Figure 3). Within the Oceania group, the FP
strains are distributed into two distinct clusters: PF/NC/VU that
also comprises strains collected in NC and Vanuatu, and PF/WF
that includes the strain from Wallis & Futuna. This observation
suggests that the recent emergence of DENV-4 in FP results from
multiple introductions of strains circulating in different SPICs.
Both clusters circulated from March 2009 to June 2010. However,
PF/NC/VU is widely distributed in the different FP archipelagos
whereas PF/WF only comprises strains collected in the Society
Table 4. Relevant amino acid substitutions on the E protein based on the consensus sequence of 142 DENV-4 strains.
Clade Group Substitutions Comments
IIa Oceania M/I34T TO08/14
I/A46T* Clade IIa (except WF09/010409-1); Clade IIb (except PF82/5918)
I/T46A WF09/010409-1
L82P TO08/14
S120L Clade IIa (except MY01a)
S156P TO08/14
V160M PF10/170510-192
V173I PF09/310309-162
N276S PF09/141009-111
K323Q PF09/190509-238
V335I Oceania group, MY01a (Clade IIa); TH63 (Genotype I); Genotype IV
T365I* Oceania group
I380V KI08/266
D/E384N* PF10/050210-117, MY01a (Clade IIa); LK78 (Genotype I); Clade IIb
IIb PF80s I/A46T* Clade IIb (except PF82/5918); Clade IIa (except WF09/010409-1)
V/A141I PF85/U18439
D/S154G PF88/130-74
T155I PF82/5918; ID73, CN78b (Clade IIa); PH56, TH63 (Genotype I)
K/E202R PF79; TH63, LK78 (Genotype I)
T221A PF82/5918; CN, PH56, PH64, PH84 (Genotype I)
A/T222V PF87/19-7
S/L/A227T PF80s group (except PF79/U18438, PF82/5918, PF85/323-103)
V287I PF80s group (except PF79/U18438)
I351V PF80s group (except PF79/U18438); most strains from Genotype IIb; CN, PH84 (Genotype I)
P356L PF88/130-74
F357L Clade IIb; ID73 (Genotype IIa); PH56, PH64, PH84, TH63, TH84 (Genotype I)
D/E384N* Clade IIb; PF10/050210-117, MY01(Clade IIa); LK78 (Genotype I)
*non conservative aa substitution; strains of interest are in bold characters.
archipelago. Interestingly, the early dissemination of the virus
started in the Leeward Islands within PF/NC/VU and in Tahiti
within PF/WF. This observation suggests that in addition to be a
main entry point for emergent DENV serotypes, the Leeward
Islands should also be considered as an efficient starting point for
active dissemination of the virus throughout all FP. The analysis of
the nt substitutions within the two clusters compared to the
Solomon Island strain [SB07/EU448462] reveals two nt substi-
tutions specific to PF/NC/VU and another substitution specific to
PF/WF (Table 3). Moreover, within each cluster, all FP strains
share one additional nt substitution. Particularly, all FP strains in
cluster PF/WF exhibit a nt substitution (C1465T) in the genomic
E/NS1 junction region which is propitious to the study of
evolutionary characteristics [4]. All of these nt substitutions are
synonymous, showing that no major mutational event occurred on
the E gene from the first emergence of DENV-4 genotype IIa in
the Solomon Islands in 2007 to the current circulation in FP.
Interestingly, some specific missense mutations resulting in aa
substitutions occurred on the E gene of the strains collected in
Kiribati and Tonga (Table 4).
A more global analysis of the aa changes on the E protein based
on the consensus aa sequence of 142 DENV-4 strains reveals
mutations that are specific to strains collected in the South Pacific.
Within genotype IIb, all the strains composing the PF80s group,
except [PF79/U18438], exhibited the same substitution V287I
within the domain I of the E gene [42]. Within genotype IIa, all
the strains belonging to the Oceania group show two substitutions
(V335I and T365I) already described [22,42]. These mutations
occurred within the domain III that mediates DENV binding to
cellular receptors and has been proved to be highly immunogenic
[42,43]. Our results show that in the 1980s like in the recent
emergence of DENV-4 in the region, specific aa substitutions
might have been acquired and subsequently conserved on all
strains circulating in the SPICs during periods ranging from 3
(20072010) to 5 (19831988) years. In a previous study,
investigating the microevolution of DENV-1 during 6 years of
sustained circulation in FP, two specific aa substitutions on the E
protein, that appeared during the endemic transmission period
and were rapidly stabilized, were suggestive of an adaptation to the
mosquito vector [18]. In the present study, the aa substitutions on
the E protein found on all DENV-4 strains collected in the SPICs
could reflect a founder effect, to be associated with either one or
several factors characterizing the South Pacific Islands context:
insularity, climate, presence of endemic vector species, small
human population sizes and low population flows.
Acknowledgments
We are grateful to Myrielle Dupont-Rouzeyrol, Olivia OConnor and
Suzanne Chanteau from the Institut Pasteur de Nouvelle Caledonie
(Noumea, New Caledonia) and Jean-Francois Yvon from the Laboratoire
danalyses de lhopital de Sia (Wallis, Wallis & Futuna) for providing blood
samples blotted on filter paper cards from DENV-4 infected patients.
Author Contributions
Conceived and designed the experiments: V-MC-L CR MA. Performed
the experiments: MA AT. Analyzed the data: V-MC-L CR. Contributed
reagents/materials/analysis tools: V-MC-L SL ED H-PM DM JA. Wrote
the paper: V-MC-L CR SL ED DM JA.
References
1. World Health Organization (2008) Dengue and dengue haemorrhagic fever.
Factsheet Nu117 revised March 2009. Geneva: World Health Organization,
Available: http://www.who.int/mediacentre/factsheets/fs117/en. Accessed
2011 Dec 1.
2. Rosen L, Rozeboom LE, Sweet BH, Sabin AB (1954) The transmission of
Dengue by Aedes polynesiensis Marks. Am J Trop Med Hyg 3: 878882.
3. World Health Organization (2009) Dengue: Guidelines for diagnosis, treatment,
prevention and control. New edition. Geneva: TDR/WHO, Available: http://
whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf. Accessed 2011
Dec 1.
4. Rico-Hesse R (1990) Molecular evolution and distribution of dengue viruses type
1 and 2 in nature. Virology 174: 479493.
5. Pandey BD, Igarashi A (2000) Severity-related molecular differences among
nineteen strains of Dengue type 2 viruses. Microbiol Immunol 44: 179188.
6. Rico-Hesse R (2003) Microevolution and virulence of Dengue viruses. Adv Virus
Res 59: 315341.
7. Anderson JR, Rico-Hesse R (2006) Aedes aegypti vectorial capacity is determined
by the infecting genotype of dengue virus. Am J Trop Med Hyg 75: 886882.
8. Alliot FA (1887) Etude sur une epidemie de dengue observee a` Tahiti. Janvier a`
Mai 1885. Sa propagation a` bord de laviso le Volage. Bordeaux Th Med 1886
1887 #78. 35 p.
9. Laigret J, Rosen L, Scholammer G (1967) Sur une epidemie de Dengue
survenue a` Tahiti en 1964. Relations avec les Fie`vres Hemorragiques du Sud-
Est asiatique. Bull Soc Pathol Exot 60: 339353.
10. Saugrain J, Rosen L, Outin-Fabre D, Moreau JP (1970) Une recente epidemie
darbovirose du type Dengue a` Tahiti. Comparaison avec lepidemie de 1964.
Bull Soc Pathol Exot 63: 631641.
11. Singh N, Kierdzynski T, Lepers C, Benyon EK (2005) Dengue in the Pacific
an update of the current situation. Pac Health Dialog 12: 111119.
12. Moreau JP, Rosen L, Saugrain J, Lagraulet J (1973) An epidemic of Dengue on
Tahiti associated with hemorrhagic manifestations. Am J Trop Med Hyg 22:
237241.
13. Gubler DJ, Reed D, Rosen L, Hitchcock JR, Jr. (1978) Epidemiologic, clinical,
and virologic observations on Dengue in the Kingdom of Tonga. Am J Trop
Med Hyg 27: 581589.
14. A-Nuegoonpipat A, Berlioz-Arthaud A, Chow V, Endy T, Lowry K, et al. (2004)
Sustained transmission of dengue virus type 1 in the Pacific due to repeated
introductions of different Asian strains. Virology 329: 505512.
15. Imrie A, Zhao Z, Bennett SN, Kitsutani P, Laille M, et al. (2006) Molecular
epidemiology of dengue in the Pacific: introduction of two distinct strains of
dengue virus type-1 into Hawaii. Ann Trop Med Parasitol 100: 327336.
16. Laille M, Roche C (2004) Comparison of Dengue-1 virus envelope glycoprotein
gene sequences from French Polynesia. Am J Trop Med Hyg 71: 478484.
17. Wiegant A, Renou L, Louette R, Melix G, Hirshauer C, et al. (2007) Dengue
fever epidemiology and related control strategies in French Polynesia
20062007. InformACTION #27. Available: http://www.spc.int/phs
/ENGLISH/Publications/InformACTION/IA27-contents.htm. Accessed
2011 Dec 1.
18. Descloux E, Cao-Lormeau VM, Roche C, de Lamballerie X (2009) Dengue 1
diversity and microevolution, French Polynesia 20012006: connection with
epidemiology and clinics. PLoS Negl Trop Dis 3: e493.
19. Daudens E, Laste`re S, Hirschauer C, Cao-Lormeau VM, Louette R, et al.
(2009) Epidemiology of dengue and control strategies in French Polynesia from
2006 to 2008. BEH thematique 48-49-50: 499503.
20. Lepers C (2008) Dengue fever situation in the Pacific Island Countries and
Territories, 30 September 2008. InformACTION #29. Available: http:
//www.spc.int/phs/ENGLISH/Publications/InformACTION/IA29-contents.
htm. Accessed 2011 Dec 1.
21. Shu PY, Su CL, Liao TL, Yang CF, Chang SF, et al. (2009) Molecular
characterization of dengue viruses imported into Taiwan during 20032007:
geographic distribution and genotype shift. Am J Trop Med Hyg 80: 10391046.
22. Li DS, Liu W, Guigon A, Mostyn C, Grant R, et al. (2010) Rapid displacement
of dengue virus type 1 by type 4, pacific region, 20072009. Emerg Infect Dis
16: 123125.
23. Parc F, Pichon G, Tetaria C, Louis F, Laigret J (1981) La Dengue due au virus
de type 4 en Polynesie francaise. I - Epidemiologie generale, aspects cliniques
particuliers. Med Trop 41: 9396.
24. Chungue E, Cassar O, Drouet MT, Guzman MG, Laille M, et al. (1995)
Molecular epidemiology of Dengue-1 and Dengue-4 viruses. J Gen Virol 76:
18771884.
25. Johnson BW, Russell BJ, Lanciotti RS (2005) Serotype-specific detection of
dengue viruses in a fourplex real-time reverse transcriptase PCR assay. J Clin
Microbiol 43: 49774983.
26. Tamura K, Peterson D, Peterson N, Stecheir G, Nei M, et al. (2011) MEGA5:
Molecular Evolutionary Genetics Analysis using maximum likelihood evolu-
tionary distance, and maximum parsimony methods. Mol Biol Evol 28:
27312739.
27. Kimura M (1980) A simple method for estimating evolutionary rate of base
substitutions through comparative studies of nucleotide sequences. J Mol Evol
16: 111120.
28. Felsenstein J (1985) Confidence limits on phylogenies: An approach using the
bootstrap. Evolution 39: 783791.
29. Lanciotti RS, Gubler DJ, Trent DW (1997) Molecular evolution and phylogeny
of dengue-4 viruses. J Gen Virol 78: 22792284.
30. Klungthong C, Zhang C, Mammen MP, Jr., Ubol S, Holmes EC (2004) The
molecular epidemiology of dengue virus serotype 4 in Bangkok, Thailand.
Virology 329: 168179.
31. Klungthong C, Putnak R, Mammen M P, Li T, Zhang C (2008) Molecular
genotyping of dengue viruses by phylogenetic analysis of the sequences of
individual genes. J Virol Methods 154: 175181.
32. AbuBakar S, Wong PF, Chan YF (2002) Emergence of dengue virus type 4
genotype IIA in Malaysia. J Gen Virol 83: 24372442.
33. Chungue E, Deparis X, Murgue B (1998) Dengue in French Polynesia: Major
features, surveillance, molecular epidemiology and current situation. Pac Health
Dialog 5: 154162.
34. Cao-Lormeau VM, Roche C, Descloux E, Viallon J, Laste`re S, et al. (2007) Lost
in French Polynesia: which strategies for a dengue virus to spread? Am J Trop
Med Hyg 77(5 suppl): 129.
35. Bessoff K, Delorey M, Sun W, Hunsperger E (2008) Comparison of two
commercially available dengue virus (DENV) NS1 capture enzyme-linked
immunosorbent assays using a single clinical sample for diagnosis of acute
DENV infection. Clin Vaccine Immunol 15(10): 15131518.
36. Guzman MG, Jaenisch T, Gaczkowski R, Ty Hang VT, Sekaran SD, et al.
(2010) Multi-country evaluation of the sensitivity and specificity of two
commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl
Trop Dis 4(8): e811.
37. Forshey BM, Morrison AC, Cruz C, Rocha C, Vilcarromero S, et al. (2009)
Dengue virus serotype 4, Northeastern Peru, 2008. Emerg Infect Dis 15:
18151818.
38. Tang Y, Quintana M, Zhang C, Li T, Sauls D, et al. (2011) Letter to the editor:
molecular genotyping of Dengue Virus Types 2 and 4 from the Guatemalan and
Honduran Epidemics of 2007 using the envelope glycoprotein gene. Virus Genes
42: 200203.
39. De Melo FL, Romano CM, de Andrade Zanotto PM (2009) Introduction of
dengue virus 4 (DENV-4) genotype I into Brazil from Asia? PLoS Negl Trop Dis
3: e390.
40. Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, et al. (1997) Origins
of dengue type 2 viruses associated with increased pathogenicity in the Americas.
Virology 230: 244251.
41. Bennett SN, Holmes EC, Chirivella M, Rodriguez DM, Beltran M, et al. (2006)
Molecular evolution of dengue 2 virus in Puerto Rico: positive selection in the
viral envelope accompanies clade reintroduction. J Gen Virol 87: 885893.
42. Modis Y, Ogata S, Clements D, Harrison SC (2003) A ligand-binding pocket in
the dengue virus envelope glycoprotein. Proc Natl Acad Sci USA 100:
69866991.
43. Guzman MG, Hermida L, Bernardo L, Ramirez R, Guillen G (2010) Domain
III of the envelope protein as a dengue vaccine target. Expert Rev Vaccines 9:
137147.

Cao-Lormeau VM, 2011 PDF

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Cao-Lormeau VM, 2011 PDF

Uploaded by

Copyright:

Available Formats

Recent Emergence of Dengue Virus Serotype 4 in French

Polynesia Results from Multiple Introductions from Other

You might also like